to launch an authorized generic of Maxitrol (neomycin and polymyxin B sulfates and dexamethasone ophthalmic suspension), which treats and relieves bacterial eye infections. Maxitrol and generic ...

to launch an authorized generic of Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension), which treats and relieves bacterial eye infections. Maxitrol® and ...

Developed by Venus Medicine Research Centre (VMRC), the R&D division of Venus Remedies, VRP-034 is a novel supramolecular cationic (SMC) formulation of polymyxin B sulphate, uniquely developed to ...

India’s Venus Remedies (NSE: VENUSREM) has secured Qualified Infectious Disease Product designation from the US Food and Drug Administration for its investigational antibiotic VRP-034, a ...